NEW YORK STATE DEPARTMENT OF HEALTH AIDS INSTITUTE | HIVGUIDELINES.ORG
Topics, Trends & Updates
March 2021
Update: Guide to ART Drug-Drug Interactions
The New York State Department of Health (NYSDOH) AIDS Institute (AI) Clinical Guidelines Program announces that the guide to ART Drug-Drug Interactions has been updated (lead author for review and update John Faragon, PharmD, BCPS, AAHIVP, with the Medical Care Criteria Committee). 

This guide provides a central source of information on drug-drug interactions involving antiretroviral medications to assist healthcare providers in preventing or managing drug-drug interactions that could have a negative or dangerous effect on patient health. It can also help clinicians to identify drug-drug interactions that should or must be avoided and those that can be managed to alleviate adverse outcomes.
Seeking Real-Life Experiences with GOALS
was created to ease and streamline sexual history taking
for care providers and patients.

Have you used GOALS? Have you found it helpful? Has it made discussions about sexual history easier?

Please share! Real-life experience with GOALS will be used to inform and enliven an upcoming training.

Share your experience: Email Rachel Fikslin today: rfikslin@gradcenter.cuny.edu.

Don’t delay! Please get in touch by March 19.
New Medscape Commentary
The Vanguard of HIV Care: Don't Forget This Screening
Bruce E. Hirsch, MD

[Excerpt] Today, the cutting edge of clinical care overlaps with primary care. The clinical vanguard addresses the medical vulnerabilities of patients with HIV, seeking to eliminate preventable morbidity and premature death. Among this clinical vanguard is the screening for and prevention of anal cancer. With the increased longevity of people living with HIV and the nearly universal exposure to human papilloma virus (HPV), there is now potential for progression to mucosal cellular dysplasia and eventual malignancy. . .

The New York State AIDS Institute Clinical Guidelines Program recommends screening for anal dysplasia in all patients with HIV. A proactive approach similar to cervical cancer screening is appropriate and includes measures easily implemented by all clinicians:

  • History: Assess for rectal symptoms, anal pain, discharge, and lumps.
  • Physical exam: Assess for presence of perianal lesions; perform a thorough digital rectal exam.
  • Anal Pap test for anal cytology.
Don't Miss
Hot Topics
Upcoming Training, Education, and Events
Are You a Subscriber?
If this newsletter was forwarded to you, please subscribe now to make sure you receive the Clinical Guidelines Program news every month and stay current with new and updated guidelines.

Subscribing is as easy as entering your email address. We will send you just 1 email per month, and we do not share our mailing list.
Please subscribe now!
Comment? Question? Suggestion? Drop us a line: aiguidelines@mail219.jh.edu We welcome feedback and suggestions, and if you send us a question, we will get back to you as quickly as possible. Please note, however, that we cannot answer questions about the care or treatment of specific patients and cannot provide clinical advice. 

Provide feedback: Take our brief survey now.